ArticleP & T : a peer-reviewed journal for formulary management2015

Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.

Martin Paspe CruzPubMed ↗Full text ↗

No numbers read from the abstract.